🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will test if adding ruxolitinib to standard multi-drug chemother...
Status
Recruiting
Location
University of Chicago Medical Center
Start Date
2019-05-28
Trial ID
NCT03571321
The purpose of phase 1 part in this study was to determine the maximum tole...
Status
Completed
Location
Site JP81037
Start Date
2015-02-26
Trial ID
NCT02310321
Treatments Being Tested
This is a phase II study designed to investigate the combination of bortezo...
Status
Terminated
Location
Children's Mercy Hospital
Start Date
2015-07
Trial ID
NCT02535806
This is a Phase 1b, open-label study evaluating Venetoclax in combination w...
Status
Recruiting
Location
Montefiore Einstein Cancer Center and Children's Hospital at Montefiore (CHAM)
Start Date
2022-05-25
Trial ID
NCT05342584
Treatments Being Tested
This phase II trial is to see if combining bevacizumab with idarubicin and ...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2001-07
Trial ID
NCT00023920
Treatments Being Tested
This phase I/II trial studies the safety, side effects, and best dose of de...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-09-23
Trial ID
NCT06928662
A phase I clinical study in evaluation of RAD 001 with aracytine and daunor...
Status
Completed
Location
Sophie Park
Start Date
2008-02
Trial ID
NCT01074086
Treatments Being Tested
H. Lee Moffitt Cancer Center and Research Institute will be the Sunshine Pr...
Status
Completed
Location
Holtz Children's Hospital University of Miami Miller School of Medicine
Start Date
2011-07-18
Trial ID
NCT01324180
Treatments Being Tested
The purpose of this research study is to identify better ways to treat chil...
Status
Completed
Location
Jersey Shore University Medical Center
Start Date
2001-02
Trial ID
NCT00176462
Evaluate the response (complete hematologic response \[CHR\], complete cyto...
Status
Unknown
Location
Hospital Germans Trias i Pujol
Start Date
2016-06
Trial ID
NCT02776605